Neumora Therapeutics, Inc. Common Stock (NMRA) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 153.43M | 190.54M | 177.08M | 222.91M | 254.87M | 314.06M | 348.61M | 398.32M | 442.79M | 478.28M | 525.74M | 336.61M |
| Cash & Short-Term Investments | 147.07M | 182.53M | 171.53M | 217.59M | 249.35M | 307.58M | 341.31M | 371.64M | 422.71M | 453.98M | 509.56M | 324.2M |
| Cash Only | 147.07M | 182.53M | 129.07M | 124.52M | 126.86M | 142.15M | 275.71M | 150.68M | 182.93M | 374.04M | 412.28M | 204.22M |
| Short-Term Investments | 0 | 0 | 42.45M | 93.06M | 122.49M | 165.43M | 65.59M | 220.96M | 239.79M | 79.94M | 97.28M | 119.98M |
| Accounts Receivable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.63M | 906K | 939K | 668K | 594K |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 6.36M | 8.01M | 5.56M | 5.32M | 5.51M | 6.48M | 7.3M | 0 | 0 | 0 | 0 | 0 |
| Total Non-Current Assets | 443K | 510K | 751K | 916K | 1.88M | 2.92M | 3.93M | 6.15M | 7.43M | 17.92M | 19.01M | 23.34M |
| Property, Plant & Equipment | 390K | 457K | 554K | 618K | 1.88M | 2.92M | 3.93M | 4.94M | 5.91M | 6.86M | 7.89M | 8.68M |
| Fixed Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 302K | 9.85M | 9.91M | 9.89M |
| Other Non-Current Assets | 53K | 53K | 197K | 298K | 0 | 0 | 0 | 1.21M | 1.21M | 1.21M | 1.21M | 4.77M |
| Total Assets | 153.88M | 191.05M | 177.83M | 223.82M | 256.75M | 316.97M | 352.54M | 404.47M | 450.21M | 496.19M | 544.75M | 359.95M |
| Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - |
| Asset Growth % | -40.07% | -39.73% | -49.56% | -44.66% | -42.97% | -36.12% | -35.28% | 12.37% | 14.82% | 16.41% | - | -1% |
| Total Current Liabilities | 30.11M | 32.45M | 25.84M | 21.16M | 28.38M | 29.89M | 31.74M | 23.13M | 24.61M | 25.11M | 29.12M | 26.09M |
| Accounts Payable | 5.06M | 3.38M | 549K | 644K | 1.05M | 3.31M | 6.11M | 1.08M | 1.49M | 337K | 2.23M | 8.17M |
| Days Payables Outstanding | 47.45K | - | 10.98 | - | - | - | - | - | - | 711.06 | - | - |
| Short-Term Debt | 291K | 284K | 256K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 24.77M | 28.79M | 25.04M | 6.73M | 6.28M | 10.11M | 22.89M | 7.59M | 4.79M | 10.15M | 9.73M | 6.95M |
| Current Ratio | 5.09x | 5.87x | 6.85x | 10.54x | 8.98x | 10.51x | 10.98x | 17.22x | 17.99x | 19.05x | 18.05x | 12.90x |
| Quick Ratio | 5.09x | 5.87x | 6.85x | 10.54x | 8.98x | 10.51x | 10.98x | 17.22x | 17.99x | 19.05x | 18.05x | 12.90x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 53.08M | 54.73M | 19.83M | 19.79M | 0 | 22K | 55K | 89K | 1.06M | 2.01M | 2.93M | 847.4M |
| Long-Term Debt | 119K | 193K | 267K | 19.45M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 0 | 0 | 339K | 0 | 0 | 0 | 0 | 938K | 1.85M | 2.75M | 3.5M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 52.96M | 54.53M | 19.56M | 0 | 0 | 22K | 55K | 89K | 122K | 155K | 188K | 843.91M |
| Total Liabilities | 83.2M | 87.18M | 45.67M | 40.95M | 28.38M | 29.91M | 31.8M | 23.21M | 25.67M | 27.12M | 32.06M | 873.49M |
| Total Debt | 410K | 477K | 523K | 19.96M | 938K | 1.85M | 2.75M | 3.61M | 4.43M | 5.23M | 6.14M | 6.82M |
| Net Debt | -146.66M | -182.05M | -128.55M | -104.56M | -125.92M | -140.29M | -272.97M | -147.07M | -178.5M | -368.81M | -406.14M | -197.4M |
| Debt / Equity | 0.01x | 0.00x | 0.00x | 0.11x | 0.00x | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | -28.51x | -28.20x | -74.98x | - | - | - | - | - | - | - | - | - |
| Total Equity | 70.68M | 103.87M | 132.16M | 182.88M | 228.36M | 287.06M | 320.74M | 381.26M | 424.54M | 469.08M | 512.69M | -513.54M |
| Equity Growth % | -69.05% | -63.82% | -58.79% | -52.03% | -46.21% | -38.8% | -37.44% | 174.24% | 16.07% | 204.97% | - | -30.11% |
| Book Value per Share | 0.39 | 0.64 | 0.82 | 1.13 | 1.41 | 1.78 | 2.01 | 2.40 | 2.69 | 2.95 | 3.30 | -3.38 |
| Total Shareholders' Equity | 70.68M | 103.87M | 132.16M | 182.88M | 228.36M | 287.06M | 320.74M | 381.26M | 424.54M | 469.08M | 512.69M | -513.54M |
| Common Stock | 18K | 17K | 16K | 16K | 16K | 16K | 16K | 16K | 16K | 16K | 15K | 3K |
| Retained Earnings | -1.24B | -1.18B | -1.12B | -1.07B | -1.02B | -947.22M | -888.4M | -815.86M | -757.15M | -703.43M | -594.7M | -541.68M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 9K | -15K | -3K | 62K | 105K | -187K | -148K | -76K | -311K | -448K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |